MedTrace Logo

the Effectiveness of Lactoferrin in Treatment of Iron Deficiency Anemia in Children With Chronic Tonsillitis

NCT03748043 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2019-03-19

No results posted yet for this study

Summary

the investigators will compare the response to iron deficiency anemia to lactoferrin plus ferrous poly maltose versus ferrous poly maltose in Children With Chronic Tonsillitis

Conditions

  • Iron-deficiency

Interventions

DRUG

Lactoferrin

lactoferrin 100 mg per day plus ferric hydroxide polymaltose 6 mg /kilogram of Elemental iron

DRUG

Ferric Hydroxide Polymaltose

group 2 will receive ferric hydroxide polymaltose 6 mg /kilogram of elemental iron

Sponsors & Collaborators

  • South Valley University

    lead OTHER

Principal Investigators

  • shimaa Ahmed, MD · South Valley University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-21
Primary Completion
2019-05-30
Completion
2019-05-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03748043 on ClinicalTrials.gov